195 related articles for article (PubMed ID: 32749938)
1. Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for
Tang W; Ren L; Liu T; Ye Q; Wei Y; He G; Lin Q; Wang X; Wang M; Liang F; Cui Y; Xu J
J Clin Oncol; 2020 Sep; 38(27):3175-3184. PubMed ID: 32749938
[TBL] [Abstract][Full Text] [Related]
2. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
Wang DS; Ren C; Li SS; Fong WP; Wu XJ; Xiao J; Li BK; Zheng Y; Ding PR; Chen G; Qiu MZ; Wang ZQ; Wang FH; Luo HY; Wang F; Wang XZ; Wang LY; Xie DJ; Chen T; Li LR; Lu ZH; Zhai XH; Liu TS; Yuan Y; Chen JQ; Tan Q; Pan ZZ; Wan DS; Zhang R; Yuan YF; Xu RH; Li YH
PLoS Med; 2024 May; 21(5):e1004389. PubMed ID: 38728364
[TBL] [Abstract][Full Text] [Related]
3. Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.
Stein A; Glockzin G; Wienke A; Arnold D; Edelmann T; Hildebrandt B; Hollerbach S; Illerhaus G; Königsrainer A; Richter M; Schlitt HJ; Schmoll HJ
BMC Cancer; 2012 Aug; 12():356. PubMed ID: 22897915
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer.
Kemeny NE; Jarnagin WR; Capanu M; Fong Y; Gewirtz AN; Dematteo RP; D'Angelica MI
J Clin Oncol; 2011 Mar; 29(7):884-9. PubMed ID: 21189384
[TBL] [Abstract][Full Text] [Related]
5. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.
Nordlinger B; Sorbye H; Glimelius B; Poston GJ; Schlag PM; Rougier P; Bechstein WO; Primrose JN; Walpole ET; Finch-Jones M; Jaeck D; Mirza D; Parks RW; Collette L; Praet M; Bethe U; Van Cutsem E; Scheithauer W; Gruenberger T; ; ; ; ;
Lancet; 2008 Mar; 371(9617):1007-16. PubMed ID: 18358928
[TBL] [Abstract][Full Text] [Related]
6. Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.
Chun YS; Passot G; Yamashita S; Nusrat M; Katsonis P; Loree JM; Conrad C; Tzeng CD; Xiao L; Aloia TA; Eng C; Kopetz SE; Lichtarge O; Vauthey JN
Ann Surg; 2019 May; 269(5):917-923. PubMed ID: 28767562
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents.
García-Alfonso P; Ferrer A; Gil S; Dueñas R; Pérez MT; Molina R; Capdevila J; Safont MJ; Castañón C; Cano JM; Lara R
Target Oncol; 2015 Dec; 10(4):453-65. PubMed ID: 25752908
[TBL] [Abstract][Full Text] [Related]
8. Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report.
Malavasi N; Ponti G; Depenni R; Bertolini F; Zironi S; Luppi G; Conte PF
J Hematol Oncol; 2009 Aug; 2():35. PubMed ID: 19660136
[TBL] [Abstract][Full Text] [Related]
9. Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.
Yamashita S; Brudvik KW; Kopetz SE; Maru D; Clarke CN; Passot G; Conrad C; Chun YS; Aloia TA; Vauthey JN
Ann Surg; 2018 Mar; 267(3):514-520. PubMed ID: 28002060
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial.
Schulze T; Kemmner W; Weitz J; Wernecke KD; Schirrmacher V; Schlag PM
Cancer Immunol Immunother; 2009 Jan; 58(1):61-9. PubMed ID: 18488223
[TBL] [Abstract][Full Text] [Related]
11. A caution against KRAS-guided margin width during hepatectomy for colorectal liver metastases.
Haddad A; Vauthey JN; Newhook TE
Surgery; 2024 Jul; 176(1):134-136. PubMed ID: 38632003
[No Abstract] [Full Text] [Related]
12. TP53 Alteration and Its Effect on Pathologic Response Are Associated with Survival after Resection of Colorectal Liver Metastases.
Maki H; Haddad A; Ayabe RI; Lendoire M; Khanduri I; Maru DM; Vauthey JN
J Gastrointest Surg; 2023 Nov; 27(11):2597-2600. PubMed ID: 37553514
[TBL] [Abstract][Full Text] [Related]
13. Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab.
Matsunaga M; Miwa K; Oka Y; Nagasu S; Sakaue T; Fukahori M; Ushijima T; Akagi Y
Case Rep Oncol; 2016; 9(1):249-54. PubMed ID: 27239180
[TBL] [Abstract][Full Text] [Related]
14. Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial.
Adam R; Badrudin D; Chiche L; Bucur P; Scatton O; Granger V; Ducreux M; Cillo U; Cauchy F; Lesurtel M; Mabrut JY; Verslype C; Coubeau L; Hardwigsen J; Boleslawski E; Muscari F; Jeddou H; Pezet D; Heyd B; Lucidi V; Geboes K; Lerut J; Majno P; Grimaldi L; Boukhedouni N; Piedvache C; Gelli M; Levi F; Lewin M
EClinicalMedicine; 2024 Jun; 72():102608. PubMed ID: 38721015
[TBL] [Abstract][Full Text] [Related]
15. Emerging Role of Liver Transplantation for Unresectable Colorectal Liver Metastases.
Chávez-Villa M; Ruffolo LI; Line PD; Dueland S; Tomiyama K; Hernandez-Alejandro R
J Clin Oncol; 2024 Apr; 42(10):1098-1101. PubMed ID: 38408289
[No Abstract] [Full Text] [Related]
16. Protective effect of hydrogen-rich water on liver function of colorectal cancer patients treated with mFOLFOX6 chemotherapy.
Yang Q; Ji G; Pan R; Zhao Y; Yan P
Mol Clin Oncol; 2017 Nov; 7(5):891-896. PubMed ID: 29142752
[TBL] [Abstract][Full Text] [Related]
17. Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.
Mlecnik B; Bifulco C; Bindea G; Marliot F; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Lafontaine L; Bruni D; Lanzi A; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Muşină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Fox BA; Pagès F; Galon J
J Clin Oncol; 2020 Nov; 38(31):3638-3651. PubMed ID: 32897827
[TBL] [Abstract][Full Text] [Related]
18. Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer.
Cremolini C; Antoniotti C; Stein A; Bendell J; Gruenberger T; Rossini D; Masi G; Ongaro E; Hurwitz H; Falcone A; Schmoll HJ; Di Maio M
J Clin Oncol; 2020 Aug; ():JCO2001225. PubMed ID: 32816630
[TBL] [Abstract][Full Text] [Related]
19. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
André T; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt C; Smith D; Garcia-Carbonero R; Benavides M; Gibbs P; de la Fouchardiere C; Rivera F; Elez E; Bendell J; Le DT; Yoshino T; Van Cutsem E; Yang P; Farooqui MZH; Marinello P; Diaz LA;
N Engl J Med; 2020 Dec; 383(23):2207-2218. PubMed ID: 33264544
[TBL] [Abstract][Full Text] [Related]
20. Limitations in resectability of colorectal liver metastases 2020 - A systematic approach for clinicians and patients.
Schadde E; Grunhagen DJ; Verhoef C; Krzywon L; Metrakos P
Semin Cancer Biol; 2021 Jun; 71():10-20. PubMed ID: 32980499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
